Global Wealth Management Investment Advisory, Inc. Cytosorbents Corp Transaction History

Global Wealth Management Investment Advisory, Inc.

$429 Million
Q2 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$6.28 - $10.59 $942 - $1,588	-150 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.77 - $7.73 $565 - $1,159	150 New	150 $1,000
Q2 2019 Aug 20, 2019	SELL	$5.92 - $7.78 $444 - $583	-75 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$6.82 - $8.56 $3,669 - $4,605	-538 Reduced 87.77%	75 $1,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $4,321 - $7,748	613 New	613 $5,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.9M

Call Options Held

10.1K

Put Options Held

500

Avenir Corp Washington, DC

2.97M
Shares

$3.53 Million
0.21% of portfolio
Skylands Capital, LLC

2.84M
Shares

$3.38 Million
0.3% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.66M
Shares

$3.17 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.32 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.54M
Shares

$1.83 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.

Account